Lily Li
Senior Director of Lab Process and Platform Develo
Biotech
BioAnalytix
Japan
Biography
Dr. Li is Sr Director of Process and Platform Development of BioAnalytix. Previously Dr. Li was Laboratory Director at Tandem Labs and prior to that she was Head of PharmaKD, which was acquired by Tandem Labs. While at Tandem Labs, Dr. Li built proprietary platforms along with QA/QC processes to support pharmaceutical research and development from early discovery to clinical development. Before joining PharmaKD/Tandem, Dr. Li was the Director of Analytics, Mass Spectrometry and the Founding Scientist, where she developed innovative analytic platforms and set up a QA/QC process to be qualified as a CLIA certified laboratory. As Head of High Throughput Analytics at Monsanto, she was responsible for the development of biochemical profiling platforms which were used to support Monsanto company-wide Genomics pipeline and Biotech research projects. Dr. Li is a co-author on several patents in methods and process of small and large molecules analysis. Dr. Li was an NIH post-doctoral fellow in Drug Testing and Toxicology and received her Ph.D. in Food Chemistry at Cornell University. She earned her M.S. in Nutritional Biochemistry at University of Illinois, Urbana-Champaign.
Research Interest
Biotechnology